Description
Sent on March 3, 2014, this letter summarizes the ISDS Board of Directors' response to preliminary recommendations that Laboratory Reporting and Syndromic Surveillance be removed as core measures for Eligible Hospitals in Stage 3 Meaningful Use. The letter strongly opposes this initial recommendation.